The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic

For around three decades, the fluoroquinolone (FQ) antibiotic ciprofloxacin has been used to treat a range of diseases, including chronic otorrhea, endocarditis, lower respiratory tract, gastrointestinal, skin and soft tissue, and urinary tract infections. Ciprofloxacin's main mode of action is...

Descripción completa

Detalles Bibliográficos
Autores principales: Shariati, Aref, Arshadi, Maniya, Khosrojerdi, Mohammad Ali, Abedinzadeh, Mostafa, Ganjalishahi, Mahsa, Maleki, Abbas, Heidary, Mohsen, Khoshnood, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815622/
https://www.ncbi.nlm.nih.gov/pubmed/36620240
http://dx.doi.org/10.3389/fpubh.2022.1025633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815622/
https://www.ncbi.nlm.nih.gov/pubmed/36620240
http://dx.doi.org/10.3389/fpubh.2022.1025633

Ejemplares similares